SERPINB13 is a serine protease inhibitor that plays important roles in keratinocyte biology and tissue homeostasis. The protein functions as a transcriptional target of RUNX1, which binds to the SERPINB13 promoter to repress its expression, leading to increased cathepsin K activity when SERPINB13 is downregulated 1. SERPINB13 appears to have protective functions in epithelial tissues, as its downregulation is significantly associated with poor clinical outcomes in head and neck squamous cell carcinomas, including poor tumor differentiation, lymph node metastasis, and decreased patient survival 2. The gene shows tissue-specific expression patterns and serves as a biomarker for vaginal secretions in forensic applications 3. Interestingly, SERPINB13 may influence immune responses, as anti-SERPINB13 antibodies are associated with reduced autoimmune inflammation in type 1 diabetes models 4. The protein is differentially expressed in various pathological conditions, including pterygium where it is upregulated and associated with keratinization pathways 5, allergic dermatitis 6, and lung cancer subtypes where it helps distinguish adenocarcinoma from squamous cell carcinoma 7. These findings suggest SERPINB13 functions as both a protease inhibitor maintaining cellular homeostasis and a biomarker for various disease states.